bromodeoxyuridine has been researched along with su 11248 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aita, Y; Hara, H; Ikeda, T; Ishii, KA; Isobe, K; Kawakami, Y; Saito, Y; Shimano, H; Takekoshi, K; Tanaka, Y | 1 |
1 other study(ies) available for bromodeoxyuridine and su 11248
Article | Year |
---|---|
Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Apoptosis; bcl-Associated Death Protein; Blotting, Western; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Coloring Agents; In Situ Nick-End Labeling; Indicators and Reagents; Indoles; Microarray Analysis; Oncogene Protein v-akt; PC12 Cells; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Rats; Ribosomal Protein S6 Kinases; RNA, Small Interfering; Signal Transduction; Sunitinib; Tetrazolium Salts; Thiazoles; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor Receptor-2 | 2012 |